Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists

被引:13
|
作者
Vidal, Benjamin [1 ]
Bolbos, Radu [2 ]
Redoute, Jerome [2 ]
Langlois, Jean-Baptiste [2 ]
Costes, Nicolas [2 ]
Newman-Tancredi, Adrian [3 ]
Zimmer, Luc [1 ,2 ,4 ,5 ]
机构
[1] Univ Lyon, Lyon Neurosci Res Ctr, CNRS, INSERM, Bron, France
[2] CERMEP Imagerie Vivant, Bron, France
[3] Neurolixis SAS, Castres, France
[4] Hosp Civils Lyon, Lyon, France
[5] Natl Inst Nucl Sci & Technol, Saclay, France
关键词
5-HT1A receptor; NLX-112; NLX-101; Biased agonism; phMRI; fMRI; SIGNAL-TRANSDUCTION; IN-VIVO; RAT-BRAIN; NLX-112; MODULATION; F-13640; PROFILE; F15599; MODEL;
D O I
10.1016/j.neuropharm.2019.107867
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The emerging concept of "biased agonism" denotes the phenomenon whereby agonists can preferentially direct receptor signalling to specific intracellular responses among the different transduction pathways, thus potentially avoiding side effects and improving therapeutic effects. The aim of this study was to investigate biased agonism by using pharmacological magnetic resonance imaging (phMRI). The cerebral blood oxygen level dependent (BOLD) signal changes induced by increasing doses of two serotonin 5-HT1A receptor biased agonists, NLX-112 and NLX-101, were mapped in anaesthetized rats. Although both compounds display high affinity, selectivity and agonist efficacy for 5-HT1A receptors, NLX-101 is known to preferentially activate post-synaptic receptors, whereas NLX-112 targets both pre- and post-synaptic receptors. We used several doses of agonists in order to determine if the regional selectivity of NLX-101 was dose-dependent. NLX-112 and NLX-101 induced different positive and negative hemodynamic changes patterns at equal doses. Importantly, NLX-101 had no significant effect in regions expressing presynaptic receptors contrary to NLX-112. NLX-112 also produced higher BOLD changes than NLX-101 in the orbital cortex, the somatosensory cortex, and the magnocellular preoptic nuclei. In other regions such as the retrosplenial cortex and the dorsal thalamus, the drugs had similar effects. In terms of functional connectivity, NLX-112 induced more widespread changes than NLX-101. The present phMRI study demonstrates that two closely-related agonists display notable differences in their hemodynamic "fingerprints". These data support the concept of biased agonism at 5-HT1A receptors and raise the prospect of identifying novel therapeutics which exhibit improved targeting of brain regions implicated in neuropsychiatric disorders. This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PharmacoMRI to Investigate the Functional Selectivity of 5-HT1A Receptor Biased Agonists
    Vidal, Benjamin
    Bolbos, Radu
    Redoute, Jerome
    Langlois, Jean-Baptiste
    Costes, Nicolas
    Newman-Tancredi, Adrian
    Zimmer, Luc
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 535 - 535
  • [2] A simultaneous PET-MRI study for the exploration of the pharmacological concept of 5-HT1A receptor biased agonists
    Vidal, B.
    Fieux, S.
    Villien, M.
    Le Bars, D.
    Newman-Tancredi, A.
    Costes, N.
    Zimmer, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 11 - 11
  • [3] 5-HT1A biased agonists induce different hemodynamic responses: a pharmacological MRI study
    Vidal, B.
    Bolbos, R.
    Redoute, J.
    Langlois, J. B.
    Fieux, S.
    Bouillot, C.
    Costes, N.
    Newman-Tancredi, A.
    Zimmer, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S642 - S643
  • [4] PharmacoMRI imaging of 5-HT1A receptor biased agonists
    Zimmer, L.
    Vidal, B.
    Bolbos, R.
    Redoute, J.
    Langlois, J. B.
    Costes, N.
    Newman-Tancredi, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 8 - 8
  • [5] Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
    Newman-Tancredi, Adrian
    Depoortere, Ronan Y.
    Kleven, Mark S.
    Kolaczkowski, Marcin
    Zimmer, Luc
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [6] From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery
    Sniecikowska, Joanna
    Newman-Tancredi, Adrian
    Kolaczkowski, Marcin
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (26) : 2393 - 2420
  • [7] Exploration of the concept of 5-HT1A receptor biased agonists: a PET-MRI study
    Vidal, B.
    Villien, M.
    Fieux, S.
    Le Bars, D.
    Newman-Tancredi, A.
    Costes, N.
    Zimmer, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S186 - S187
  • [8] Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.
    Vidal, Benjamin
    Fieux, Sylvain
    Villien, Marjorie
    Le Bars, Didier
    Newman-Tancredi, Adrian
    Costes, Nicolas
    Zimmer, Luc
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [9] Recent 5-HT1A receptor agonists
    Gurwitz, D
    DRUG DISCOVERY TODAY, 1999, 4 (03) : 142 - 143
  • [10] Exploration of the concept of 5-HT1A receptor biased agonists: a multimodal imaging study
    Vidal, B.
    Fieux, S.
    Redoute, J.
    Villien, M.
    Le Bars, D.
    Newman-Tancredi, A.
    Costes, N.
    Zimmer, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S643 - S644